Skip to content

TBR-652 blocks both CCR5 and CCR2, inhibiting HIV replication and reducing inflammation

Without improved infant HIV diagnosis, early treatment recommendation may have limited impact

Universal access to HIV treatment threatened by failure of will

Microbicides can work, CAPRISA trial shows, but more trials needed before approval

Adolescents living with HIV face complex psychosocial concerns: require targeted, comprehensive services

Lopinavir/ritonavir plus raltegravir NRTI-sparing regimen as effective as traditional HAART

Child mortality falls after mothers receive HIV drugs

Large-scale impact of ART on mortality in Brazil, South Africa: big successes but mind the gaps

Requiring tuberculin skin tests before implementing IPT leads to avoidable and substantial number of TB cases